UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 23, 2005
SELECT MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
Delaware
(State or other
jurisdiction of
Incorporation)
|
|
000-32499
(Commission File Number)
|
|
23-2872718
(I.R.S. Employer
Identification No.) |
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA 17055
(Address of principal executive offices) (Zip Code)
(717) 972-1100
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
| o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
| o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
| |
| o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Item 7.01 Regulation FD Disclosure
On September 16, 2005, Select Medical Holdings Corporation (“Holdings”) the parent of Select
Medical Corporation, announced that it had entered into an agreement to issue approximately $175
million of senior floating rate notes due 2015. In connection with the issuance of the senior
floating rate notes, Holdings expects to disclose to purchasers certain information that has not
been previously publicly reported. A copy of such information is attached as Exhibit 99.1 to this
report and incorporated herein by reference.
In accordance with general instruction B.2 of Form 8-K, the information in this report is furnished
and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act
of 1934, or otherwise subject to the liability of that Section .
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
Certain information which may be disclosed to purchasers of the
senior floating rate notes not previously publicly reported. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
|
|
|
|
| |
SELECT MEDICAL CORPORATION
|
|
| Date: September 23, 2005 |
By: |
/s/ Michael E. Tarvin
|
|
| |
|
Michael E. Tarvin |
|
| |
|
Senior Vice President, General Counsel and
Secretary |
|